Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Tessa Therapeutics
Feb 10, 2021
Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial
Jan 18, 2021
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Dec 17, 2020
Tessa Therapeutics Appoints David McIntyre as Chief Financial Officer
Aug 06, 2020
Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma
May 04, 2020
Tessa Therapeutics Announces New Executive Leadership
Feb 27, 2020
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma
Dec 19, 2019
Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale Cell Therapy Manufacturing Facility in Singapore in 2020
Jun 12, 2019
Tessa Therapeutics and China-Singapore Guangzhou Knowledge City Form Landmark US$120 Million Joint Venture in China to Develop Innovative Cell Therapies for Cancer
Apr 30, 2019
Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy
Apr 15, 2019
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
Feb 28, 2019
Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors
Dec 20, 2018
Distinguished Breast Cancer Expert, Dr. George W. Sledge, Jr., M.D., to join the Board of Tessa Therapeutics
Sep 20, 2018
St. Jude Children's Research Hospital and Tessa Therapeutics Announce Strategic Collaboration
Sep 19, 2018
T-Cell Immunotherapy Market, 2030 - Primary Growth Drivers and Estimations of the Future Size of the Market
Apr 11, 2018
Tessa Therapeutics announces new Board Member and increase of recent funding round
Feb 05, 2018
Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial
Dec 19, 2017
Tessa Therapeutics Closes USD 80 Million Financing Round Led by Temasek
Dec 11, 2017
Tessa Therapeutics Appoints Mr. Desmond Lim as Chief Financial Officer
Jun 19, 2017
Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement
Latest News
Apr 25, 2024
The Spaceport Company Signs Agreement with Maritime Launch to Provide Tracking and Telemetry Stations for...
Apr 25, 2024
Intevac Announces First Quarter 2024 Financial Results
Apr 25, 2024
Expro Group Holdings N.V. Announces First Quarter 2024 Results
Apr 25, 2024
Laser Photonics’ Laser Technology Meets Unique Cleaning Needs of Precision Optics Manufacturers
Apr 25, 2024
LiveWire Group, Inc. Reports 2024 First Quarter Financial Results
Apr 25, 2024
LSI Industries Reports Fiscal 2024 Third Quarter Results and Declares Quarterly Cash Dividend
Apr 25, 2024
Janus International Group to Report First Quarter 2024 Results on May 9, 2024
Apr 25, 2024
Trane Technologies Recognized as One of Europe’s Climate Leaders by Financial Times
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events